TipRanks
pc:nor12

NorthLinks Bio

Clinical-stage biotechnology company developing broad-spectrum antiviral preventive medicines for respiratory viral infections. NorthLinks Bio is advancing its lead intranasal candidate HEX17 toward Phase 2b readiness and maintains research operations in St Andrews, Scotland following a reorganization from Pneumagen Ltd.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$34M
Total Amount Raised$34M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$34M
Latest Funding Amount$34M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jun 23, 2026
Investment
$34.00M
―

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to NorthLinks Bio, helping you discover and navigate related company profiles.

Related News and Analysis